Home
Research
Submit Article
News
Sectors
Advertise
Premium
i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.
You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.
Two Week FREE Trial
About Us
About Us
Editorial Staff
Terms and Conditions
Privacy Policy
Contact Us
iStock Rating
B
Details...
Enter Symbol
C.R. Bard, Inc. (NYSE: BCR)
Sector: Medical
Current Price :
$110.58
52 Week Low
$94.70
52 Week High
$111.04
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
80M
Market Cap:
$8.94B
Avg Volume:
550491
P/E Ratio:
17.350
PEG Ratio:
1.860
Split:
On 6/1/2004 bcr split by factor of 2.000
Opinion and Analysis
C.R. Bard (BCR) 4Q Earnings Increase 13 Pct, Beat Estimates
Jan 31, 2013 04:22 PM |
BCR
C.R. Bard (BCR) Initiated at 'Hold' by Brean Capital
Nov 20, 2012 01:03 PM |
BCR
Medtronic Inc. (MDT) Dividend Stock Analysis
Sep 20, 2012 12:00 PM |
BAX
,
BCR
,
BDX
,
BLK
,
CINF
,
CVX
More Articles on BCR..
Press Releases
Bard Announces $500 Million Share Repurchase Authorization
Jun 12, 2013 04:05 PM |
BCR
Bard Increases Quarterly Dividend
Jun 12, 2013 04:05 PM |
BCR
Bard Announces First Patient Enrolled in Lutonix Below the Knee (BTK) Clinical Trial
Jun 04, 2013 11:01 AM |
BCR
More Press Releases on BCR..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
BCR
Compare to S&P
YTD
13.61 %
-0.40 %
4 Weeks
3.38 %
5.97 %
12 Weeks
10.36 %
5.62 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-15.29 %
EPS Growth in Last Year:
-10.56 %
Sales Growth in Last Quarter:
-2.92 %
Sales Growth in Last Quarter:
1.41 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##